Asparaginase and treating diseases associated with asparagine dependence
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 31, 2016
Grant Date -
Oct 29, 2015
app pub date -
May 7, 2015
filing date -
Oct 10, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein are polypeptides which exhibit asparaginase activity and little to no glutaminase activity. The polypeptides have sequences which correspond to W. succinogenes asparaginase, but have an amino acid residue other than proline at amino acid position 121. The polypeptides exhibit higher kinetic rates of asparaginase activity to glutaminase activity as compared to W. succinogenes asparaginase and Elspar®, an E. coli asparaginase.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully